The Emergence of Multidrug-Resistant Helicobacter pylori in Southeast Asia: A Systematic Review on the Trends and Intervention Strategies Using Antimicrobial Peptides

Abstract

The emergence of multidrug-resistant H. pylori poses a public healthcare threat, particularly in low- and middle-income countries. Recently, the World Health Organization has classified clarithromycin-resistant H. pylori as high priority in the research and discovery of novel antibiotics. This study was aimed to systematically review the prevalence of primary antibiotic resistance in H. pylori in Southeast Asian countries (SEAC) and to review current studies of antimicrobial peptides against H. pylori. We systematically searched through electronic databases of studies conducted on antimicrobial resistance of H. pylori in SEA countries. Furthermore, we searched articles that conducted studies on antimicrobial peptides, naturally occurring host’s defense molecules, against H. pylori. After a series of screening processes, 15 studies were included in our systematic review. Our analysis revealed that primary resistance of H. pylori to metronidazole, clarithromycin, and levofloxacin were high in SEAC, although the primary resistance to amoxicillin and tetracycline remains low. Multidrug-resistant H. pylori are emerging in SE Asian countries. The antimicrobial peptides show promising antibacterial and antibiofilm activity against drug-resistant H. pylori. The research and discovery of antimicrobial peptides against H. pylori in SEAC will help in limiting the spread of antimicrobial resistance of H. pylori.

Does technology‐enhanced communication improve Helicobacter pylori eradication outcomes?—A meta‐analysis

“…Differences in the cost of treatment were only evaluated by Al‐Eidan et al 18 It was reported that treatment accompanied by TEC would cost £8402 per hundred patients, saving an estimated £3026 over those who underwent the same eradication regime with traditional clinic visits. They suggest that this is attributed to the better eradication rates for patients undergoing TEC.…”

“…6 This is further compounded by the rising trend of resistance, partly from poor compliance, which can undermine the efficacy of treatment regimes. 18 Large-scale studies have demonstrated the effectiveness of TEC modalities in improving treatment outcomes in various other clinical scenarios. 19 However, its…”

Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy

“…In conclusion, our report confirmed that BQT is effective as an empiric second-line regimen. Therefore, its use may be recommended, but it should be adopted with caution since inappropriate use could undermine its effectiveness, taking into account the risk of tetracycline resistance spreading [ 32 , 33 ].…”

The Roles of Immune Cells in Gastric Cancer: Anti-Cancer or Pro-Cancer?

“…Mortality and incidence of gastric cancer were high in the Republic of Korea and Japan, but continuous effort for early screening and eradication of H. pylori infection has contributed to the decline of the cancer in these countries in recent years [ 18 ]. Nevertheless, the rise of antibiotic resistance of H. pylori to essential antibiotics for treatment purposes that has been observed in recent years has complicated the prevention strategy of gastric cancer, particularly in developing countries [ 19 ]. In China, the prevalence of gastric cancer is showing an overall downward trend among patients aged more than 50 years old.…”